Neuros Australia secures A$11M Series A for closed-loop sleep apnoea nerve stimulation
Summary
Brisbane-based Neuros Australia raised A$11M Series A led by Brandon Capital Partners, with Main Sequence Ventures and BioCurate. Their Dreamforge closed-loop hypoglossal nerve stimulator for obstructive sleep apnoea uses real-time respiratory sensing to trigger stimulation precisely during apnoea events, targeting a $4B+ global sleep apnoea device market.
Why it matters
Obstructive sleep apnoea affects 1 billion people globally and CPAP compliance is poor. A closed-loop implant that only stimulates when needed offers better battery life and more natural sleep than existing hypoglossal devices. Australian government R&D incentives make Brisbane an attractive base for medical device development.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial